Although still at a nascent state, quantum computing promises advances in healthcare, from drug discovery to personalised treatments. But it also threatens current cryptographic systems that protect medical data and infrastructure. The concept of…
Continue Reading
Artificial Intelligence (AI) is revolutionizing biotechnology by accelerating advancements in drug discovery, genomics, medical imaging, and personalized medicine, thereby enhancing efficiency and reducing healthcare costs. This review emphasizes the transformative potential of multimodal AI—systems…
Continue Reading
Globally, drug discovery and development programs are complex, multi-decade long and prohibitively expensive. Artificial intelligence (AI) and other digital health technologies have the potential to enhance and accelerate each stage of drug discovery and…
Continue Reading
What You Should Know:
– Heart failure is a critical health issue affecting millions of Americans, and despite decades of research, effective treatment options remain limited. Traditional drug development is a slow, costly, and high-risk…
Continue Reading
What You Should Know:
– ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies….
Continue Reading
What You Should Know:
– Ginkgo Bioworks has announced a new strategic partnership with Inductive Bio and Tangible Scientific to make AI-driven “lab-in-the-loop” drug discovery more accessible to the industry.
– The collaboration combines high-throughput experimental…
Continue Reading
The integration of physics-based digital twins with data-driven artificial intelligence—termed “Big AI”—can advance truly personalised medicine. While digital twins offer individual ‘healthcasts,’ accuracy and interpretability, and AI delivers speed and flexibility, each has limitations….
Continue Reading
What You Should Know:
– Mayo Clinic announced a pivotal step toward integrating AI solutions in the clinical setting with the deployment of NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems.
– The advanced infrastructure provides…
Continue Reading
A £7.5 million global challenge prize has launched to incentivise AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS).
ALS is a form of motor neurone disease (MND) that damages the…
AI drug discovery firm Healx has partnered with SCI Ventures to find and develop therapies for spinal cord injury (SCI).
The collaboration, which was confirmed in February 2025, will see Healx’s AI platform used to…
